Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yukari Tsubata

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2022
[Clinical Trials for Older Cancer Patients]Yukari Tsubata
Clinical & Experimental Metastasis|March 11, 2024
Current pharmacologic treatment of brain metastasis in non-small cell lung cancerTakae Okuno, Takeshi Isobe, Yukari Tsubata
Cells|November 27, 2021
Current Therapeutic Strategies and Prospects for EGFR Mutation-Positive Lung Cancer Based on the Mechanisms Underlying Drug ResistanceYukari Tsubata, Ryosuke Tanino, Takeshi Isobe
Journal of Cancer Research and Therapeutics|April 26, 2012
Erlotinib-induced acute interstitial lung disease associated with extreme elevation of the plasma concentration in an elderly non-small-cell lung cancer patientYukari Tsubata, Akinobu Hamada, Akihisa Sutani, et al.
Cureus|March 7, 2022
Drug-Induced Eosinophilic Pneumonia as an Adverse Event of AbemaciclibYuki Mitarai, Yukari Tsubata, Miki Hyakudomi, et al.
Cureus|March 1, 2022
Multiple Mass Lesions in Pneumocystis PneumoniaMisato Kobayashi, Yukari Tsubata, Yohei Shiratsuki, et al.
Oncotarget|April 24, 2018
Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancerRyosuke Tanino, Yukari Tsubata, Nanae Harashima, et al.
Internal Medicine (Tokyo, Japan)|September 20, 2019
Acute Interstitial Lung Disease Induced by Rechallenge with CeritinibTakamasa Hotta, Tamio Okimoto, Megumi Hamaguchi, et al.
Journal of Thoracic Disease|April 12, 2021
High serum C-reactive protein levels predict survival in patients with treated advanced lung adenocarcinomaTakamasa Hotta, Kazuhisa Nakashima, Kojiro Hata, et al.
Thoracic Cancer|February 4, 2021
Reproducible abscopal effect in a patient with lung cancer who underwent whole-brain irradiation and atezolizumab administrationTakamasa Hotta, Takae Okuno, Mika Nakao, et al.
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2022
[Clinical Trials for Older Cancer Patients]Yukari Tsubata
Clinical & Experimental Metastasis|March 11, 2024
Current pharmacologic treatment of brain metastasis in non-small cell lung cancerTakae Okuno, Takeshi Isobe, Yukari Tsubata
Cells|November 27, 2021
Current Therapeutic Strategies and Prospects for EGFR Mutation-Positive Lung Cancer Based on the Mechanisms Underlying Drug ResistanceYukari Tsubata, Ryosuke Tanino, Takeshi Isobe
Journal of Cancer Research and Therapeutics|April 26, 2012
Erlotinib-induced acute interstitial lung disease associated with extreme elevation of the plasma concentration in an elderly non-small-cell lung cancer patientYukari Tsubata, Akinobu Hamada, Akihisa Sutani, et al.
Cureus|March 7, 2022
Drug-Induced Eosinophilic Pneumonia as an Adverse Event of AbemaciclibYuki Mitarai, Yukari Tsubata, Miki Hyakudomi, et al.
Cureus|March 1, 2022
Multiple Mass Lesions in Pneumocystis PneumoniaMisato Kobayashi, Yukari Tsubata, Yohei Shiratsuki, et al.
Oncotarget|April 24, 2018
Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancerRyosuke Tanino, Yukari Tsubata, Nanae Harashima, et al.
Internal Medicine (Tokyo, Japan)|September 20, 2019
Acute Interstitial Lung Disease Induced by Rechallenge with CeritinibTakamasa Hotta, Tamio Okimoto, Megumi Hamaguchi, et al.
Journal of Thoracic Disease|April 12, 2021
High serum C-reactive protein levels predict survival in patients with treated advanced lung adenocarcinomaTakamasa Hotta, Kazuhisa Nakashima, Kojiro Hata, et al.
Thoracic Cancer|February 4, 2021
Reproducible abscopal effect in a patient with lung cancer who underwent whole-brain irradiation and atezolizumab administrationTakamasa Hotta, Takae Okuno, Mika Nakao, et al.
Pageof 13